当前位置: 首页 > 期刊 > 《青岛大学医学院学报》 > 20183
编号:13581340
上皮性卵巢癌组织中SMAD4基因突变的检测(4)
http://www.100md.com 2018年6月1日 《青岛大学学报(医学版)》 20183
     [22]ELLIOTT R L, BLOBE G C. Role of transforming growth factor Beta in human cancer[J]. Journal of Clinical Oncology, 2005,23(9):2078-2093.

    [23]PADUA D, MASSAGUE J. Roles of TGF beta in metastasis[J]. Cell Research, 2009,19(1):89-102.

    [24]劉景波,孔垂泽,朱育焱,等. Sma和Mad 4型同源体在前列腺增生中的表达及对前列腺细胞增殖和凋亡的影响[J]. 中华实验外科杂志, 2005,22(5):629.

    [25]ROSS S, HILL C S. How the Smads regulate transcription[J]. The International Journal of Biochemistry & Cell Biology, 2008,40(3):383-408.

    [26]刘连连,孔敏,王虹,等. 卵巢癌患者Smad4的血清水平及临床意义[J]. 中国老年学杂志, 2013,33(17):4315-4316.

    [27]WOSIAK A, WODZINSKI D, KOLASA M, et al. SMAD-4 gene expression in human colorectal cancer: comparison with some clinical and pathological parameters[J]. Pathology, Research and Practice, 2017,213(1):45-49.

    [28]SINGH P, SRINIVASAN R, WIG J D. SMAD4 genetic alte-rations predict a worse prognosis in patients with pancreatic ductal adenocarcinoma[J]. Pancreas, 2012,41(4):541-546.

    [29]PATCH A M, CHRISTIE E L, ETEMADMOGHADAM D, et al. Whole-genome characterization of chemoresistant ova-

    rian cancer[J]. Nature, 2015,521(7553):489-494., http://www.100md.com(赵慧芳 丁朝霞 姚玉霜 王敬丽 陈爱平)
上一页1 2 3 4